HF10

· Takara Bio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HF10, covering 2018-09-26 to 2018-09-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma [Phase 2]

See pricing